Enliven Therapeutics Inc (ELVN)

04:50 AM

What drives Enliven Therapeutics Inc. stock priceTremendous wealth creation - PrintWeekIndia

04:50 AM

02:43 AM

Will Enliven Therapeutics Inc. stock split in the near futureMoney Making Low Risk Plans - Newser

02:43 AM

01:59 AM

What risks could impact Enliven Therapeutics Inc. stock performanceFree Stock Index Interpretation - jammulinksnews.com

01:59 AM

Jul 24, 2025

Polis encourages life-sciences companies to move to Colorado - BizWest

Jul 24, 2025

Jul 23, 2025

Enliven Therapeutics Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Enliven Therapeutics Inc. stockOutstanding investment returns - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Enliven Therapeutics Inc. a good long term investmentTriple-digit growth rates - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares - Investing.com Australia

Jul 23, 2025

Jul 23, 2025

Enliven Therapeutics CSO sells $278k in shares By Investing.com - Investing.com India

Jul 23, 2025

Jul 23, 2025

Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know - MSN

Jul 23, 2025

Jul 23, 2025

Samuel Kintz Sells 12,500 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - Defense World

Jul 23, 2025

Jul 22, 2025

Why Enliven Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 22, 2025

Jul 20, 2025

Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect? - MSN

Jul 20, 2025

Jul 19, 2025

Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers - The Globe and Mail

Jul 19, 2025

Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025

Jul 17, 2025

Enliven Therapeutics’ Promising CML Treatment: A Study Update - TipRanks

Jul 17, 2025

Jul 15, 2025

What makes Enliven Therapeutics Inc. stock price move sharplyFree Investment Community - Newser

Jul 15, 2025

Jul 15, 2025

How Enliven Therapeutics Inc. stock performs during market volatilityInsider Strategy Insight - Newser

Jul 15, 2025

Jul 15, 2025

(ELVN) Proactive Strategies - news.stocktradersdaily.com

Jul 15, 2025

Jul 15, 2025

Enliven Therapeutics CFO Hohl sells $22,655 in shares - Investing.com Australia

Jul 15, 2025

Jul 14, 2025

Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Target Price at $41.20 - Defense World

Jul 14, 2025

Jul 10, 2025

Enliven Therapeutics Breaks Above 200-Day Moving AverageBullish for ELVN - Nasdaq

Jul 10, 2025

Jul 09, 2025

Enliven Therapeutics COO Patel sells shares worth $131950 By Investing.com - Investing.com Canada

Jul 09, 2025